Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Completed · Phase 4

Conditions studied: Rhinitis, Allergic, Seasonal

In brief

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

Key facts

Study ID

NCT00435461

Run by

GlaxoSmithKline

People needed

1000

Starts

2006-12-20

Expected to finish

2007-02-28

Last updated by the study team

2018-03-07

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed consent.
• Outpatient.
• Females of child-bearing potential must use appropriate contraception.
• Diagnosis of seasonal allergic rhinitis to mountain cedar.
• Adequate exposure to allergen.
• Able to comply with study procedures.
• Literate.

You may not qualify if…

• Significant concomitant medical condition.
• Use of corticosteroids, allergy medications, or other medication that affect allergic rhinitis
• Positive pregnancy test.
• Allergy to any component of the investigational product.
• Tobacco use
• Contact lens use
• Has chickenpox or measles or recent exposure
• Other clinical trial drug exposure in last 30 days
• Affiliation with clinic site

Where it is running

• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Kerrville, Texas, United States
• GSK Investigational Site — New Braunfels, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.